Global Abdominal Aortic Stent Graft Market Size By Type (Metal Stent, Polymer Stent), By Application (Hospital, Medical Center), By Region, And Segment Forecasts, 2023 to 2032

The Global Abdominal Aortic Stent Graft Market was valued at USD 2.1 billion in 2023 and is projected to reach USD 3.9 billion by 2031, growing at a CAGR of 7.8% during the forecast period (2023–2031). The market is driven by the rising prevalence of abdominal aortic aneurysms (AAA), increased adoption of minimally invasive surgical techniques, and a growing elderly population susceptible to vascular conditions. Technological advancements in stent graft design, such as fenestrated and branched grafts, are further accelerating adoption across global healthcare systems. Rising healthcare expenditure and favorable reimbursement policies in developed markets are boosting the market’s overall momentum.

Drivers:

1. Rising Prevalence of Abdominal Aortic Aneurysms:

An increasing number of diagnosed AAA cases, especially among individuals aged 65 and above, is a primary growth driver. The condition’s life-threatening nature necessitates intervention, contributing to sustained demand for stent graft solutions.

2. Shift Toward Minimally Invasive Procedures:

Endovascular aneurysm repair (EVAR) using abdominal aortic stent grafts offers faster recovery, reduced hospital stays, and fewer complications compared to open surgery. This has significantly boosted patient and clinician preference for stent grafts globally.

3. Technological Innovations in Graft Design:

Advancements such as custom-fitted, fenestrated, and branched stent grafts enable the treatment of complex aneurysms with greater precision. These developments are enhancing procedural success rates and expanding the scope of endovascular solutions.

Restraints:

1. High Device and Procedure Costs:

Despite being less invasive, EVAR procedures involve high upfront device and imaging costs, limiting accessibility, particularly in low-income countries and smaller healthcare facilities.

2. Post-Procedure Complications and Monitoring:

Risks such as endoleaks, graft migration, and the need for frequent post-operative imaging pose challenges, often necessitating long-term follow-up and additional interventions, which may hinder market adoption.

Opportunity:

1. Growing Demand in Emerging Economies:

With the expansion of healthcare infrastructure and rising awareness in countries like India, China, and Brazil, manufacturers have substantial opportunities to penetrate new markets through strategic pricing and localization of production.

2. Integration with Imaging and AI:

The integration of stent graft procedures with real-time 3D imaging and artificial intelligence for planning and navigation holds potential to enhance outcomes, reduce complication rates, and improve decision-making during EVAR.

Market by System Type Insights:

By system type, Standard Stent Grafts dominated the market in 2023 due to their widespread usage in treating infrarenal AAAs. However, Fenestrated and Branched Stent Grafts are expected to experience the fastest growth over the forecast period, driven by their increasing application in complex aneurysm cases involving branch arteries and anatomically challenging regions.

Market by End-use Insights:

In terms of end-use, Hospitals and Surgical Centers held the largest market share in 2023, as most stent graft procedures are performed in advanced clinical settings. The Outpatient Surgical Centers segment is poised for rapid growth, supported by the trend toward same-day discharge and the increasing availability of advanced vascular intervention technologies in ambulatory settings.

Market by Regional Insights:

North America led the global abdominal aortic stent graft market in 2023, driven by a high prevalence of AAA, advanced healthcare infrastructure, and rapid technology adoption. Europe follows closely, with significant contributions from countries like Germany and the UK. Meanwhile, Asia-Pacific is projected to witness the fastest growth rate during the forecast period, owing to increasing healthcare investment, improved diagnosis rates, and expanding insurance coverage in countries such as China and India.

Competitive Scenario:

Key players in the Global Abdominal Aortic Stent Graft Market include Medtronic plc, Cook Medical Inc., W. L. Gore & Associates, Inc., Terumo Corporation, Endologix LLC, MicroPort Scientific Corporation, and Lombard Medical Technologies. These companies are actively investing in product development, clinical trials, and geographic expansion to solidify their market position.

Recent Developments Include:

2024: Medtronic launched its next-generation fenestrated endograft system in Europe with improved anatomical adaptability.

2023: Cook Medical received FDA approval for its latest modular stent graft designed for long-term durability.

2023: Endologix announced a strategic partnership with leading vascular centers in Asia-Pacific to pilot its new polymer-based EVAR solution.

Scope of Work – Global Abdominal Aortic Stent Graft Market

Report Metric Details

Market Size (2023) USD 2.1 billion

Projected Market Size (2031) USD 3.9 billion

CAGR (2023–2031) 7.8%

Market Segments By System Type (Standard, Fenestrated, Branched); By End-use (Hospitals, Outpatient Surgical Centers); By Region

Growth Drivers Rising prevalence of AAA, preference for minimally invasive procedures, innovation in stent graft design

Opportunities Market expansion in emerging economies, integration with advanced imaging & AI

Key Market Developments:

May 2024: Medtronic introduced a fully repositionable EVAR system designed for anatomically challenging AAA patients.

January 2024: Cook Medical began a global registry study to evaluate long-term performance of branched stent grafts.

September 2023: W. L. Gore & Associates received CE mark for its hybrid stent graft with enhanced sealing mechanisms.

FAQs:

1. What is the current market size of the Global Abdominal